Annual Cash & Cash Equivalents
$102.89 M
+$39.34 M+61.91%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual cash & cash equivalents is $102.89 million, with the most recent change of +$39.34 million (+61.91%) on December 31, 2023.
- During the last 3 years, CHRS annual cash & cash equivalents has fallen by -$438.27 million (-80.99%).
- CHRS annual cash & cash equivalents is now -80.99% below its all-time high of $541.16 million, reached on December 31, 2020.
Performance
CHRS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$97.69 M
-$61.55 M-38.65%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly cash and cash equivalents is $97.69 million, with the most recent change of -$61.55 million (-38.65%) on September 30, 2024.
- Over the past year, CHRS quarterly cash and cash equivalents has increased by +$17.43 million (+21.72%).
- CHRS quarterly cash and cash equivalents is now -81.95% below its all-time high of $541.16 million, reached on December 31, 2020.
Performance
CHRS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CHRS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.9% | +21.7% |
| 3 y3 years | -81.0% | +34.0% |
| 5 y5 years | +42.2% | +34.0% |
CHRS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.3% | +61.9% | -76.6% | +505.1% |
| 5 y | 5-year | -81.0% | +61.9% | -82.0% | +505.1% |
| alltime | all time | -81.0% | +607.3% | -82.0% | +505.1% |
Coherus BioSciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $97.69 M(-38.7%) |
| Jun 2024 | - | $159.24 M(-38.7%) |
| Mar 2024 | - | $259.77 M(+152.5%) |
| Dec 2023 | $102.89 M(+61.9%) | $102.89 M(+28.2%) |
| Sep 2023 | - | $80.26 M(+10.1%) |
| Jun 2023 | - | $72.92 M(+351.7%) |
| Mar 2023 | - | $16.14 M(-74.6%) |
| Dec 2022 | $63.55 M(-84.8%) | $63.55 M(-77.8%) |
| Sep 2022 | - | $286.81 M(+4.1%) |
| Jun 2022 | - | $275.48 M(-15.4%) |
| Mar 2022 | - | $325.68 M(-21.9%) |
| Dec 2021 | $417.19 M(-22.9%) | $417.19 M(+15.7%) |
| Sep 2021 | - | $360.54 M(+9.3%) |
| Jun 2021 | - | $329.74 M(+27.1%) |
| Mar 2021 | - | $259.49 M(-52.0%) |
| Dec 2020 | $541.16 M(+204.6%) | $541.16 M(+85.0%) |
| Sep 2020 | - | $292.46 M(+30.2%) |
| Jun 2020 | - | $224.62 M(+16.2%) |
| Mar 2020 | - | $193.25 M(+8.8%) |
| Dec 2019 | $177.67 M | $177.67 M(+7.6%) |
| Sep 2019 | - | $165.12 M(+55.9%) |
| Jun 2019 | - | $105.93 M(+29.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $81.52 M(+12.7%) |
| Dec 2018 | $72.36 M(-43.0%) | $72.36 M(-28.5%) |
| Sep 2018 | - | $101.20 M(-22.2%) |
| Jun 2018 | - | $130.00 M(+58.5%) |
| Mar 2018 | - | $82.02 M(-35.4%) |
| Dec 2017 | $126.91 M(+1.6%) | $126.91 M(-6.4%) |
| Sep 2017 | - | $135.56 M(+84.8%) |
| Jun 2017 | - | $73.35 M(-41.3%) |
| Mar 2017 | - | $124.92 M(-0.0%) |
| Dec 2016 | $124.95 M(-21.0%) | $124.95 M(-21.8%) |
| Sep 2016 | - | $159.68 M(-27.7%) |
| Jun 2016 | - | $220.92 M(+23.0%) |
| Mar 2016 | - | $179.56 M(+13.5%) |
| Dec 2015 | $158.23 M(+5.2%) | $158.23 M(+3.0%) |
| Sep 2015 | - | $153.69 M(-25.4%) |
| Jun 2015 | - | $206.09 M(+79.0%) |
| Mar 2015 | - | $115.14 M(-23.4%) |
| Dec 2014 | $150.39 M(+280.2%) | $150.39 M(+49.1%) |
| Sep 2014 | - | $100.88 M(-7.3%) |
| Jun 2014 | - | $108.87 M(+175.2%) |
| Dec 2013 | $39.55 M(+171.9%) | $39.55 M |
| Dec 2012 | $14.55 M | - |
FAQ
- What is Coherus BioSciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Coherus BioSciences?
- What is Coherus BioSciences annual cash & cash equivalents year-on-year change?
- What is Coherus BioSciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Coherus BioSciences?
- What is Coherus BioSciences quarterly cash and cash equivalents year-on-year change?
What is Coherus BioSciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CHRS is $102.89 M
What is the all time high annual cash & cash equivalents for Coherus BioSciences?
Coherus BioSciences all-time high annual cash & cash equivalents is $541.16 M
What is Coherus BioSciences annual cash & cash equivalents year-on-year change?
Over the past year, CHRS annual cash & cash equivalents has changed by +$39.34 M (+61.91%)
What is Coherus BioSciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CHRS is $97.69 M
What is the all time high quarterly cash and cash equivalents for Coherus BioSciences?
Coherus BioSciences all-time high quarterly cash and cash equivalents is $541.16 M
What is Coherus BioSciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CHRS quarterly cash and cash equivalents has changed by +$17.43 M (+21.72%)